Effects of administration of monoclonal antibodies (anti-CD4 or anti-CD8) on the development of autoimmune diseases in (NZW x BXSB)F1 mice

Immunobiology

Volumn 198, Issue 4, 1998, Pages 451-464

  Adachi, Yasushi ^a   Inaba, Muneo ^a   Sugihara, Akira ^a   Koshiji, Minori ^a   Sugiura, Kikuya ^a   Amoh, Yasuo ^a   Mori, Shin Ichiro ^a   Kamiya, Tetsuro ^b   Genba, Hisae ^a   Ikehara, Susumu ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN ANTIBODY; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; MESSENGER RNA; MONOCLONAL ANTIBODY; OKT 4; OKT 8; THROMBOCYTE ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031885580     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(98)80052-1     Document Type: Article

References (31)

1. HANG, L. M., P. STEPHENS-LARSON, and F. J. DIXON. 1983. The role of hypertension in the vascular disease and myocardial infarcts associated with murine systemic lupus erythematosus. Arthritis and Rheumatism. 26: 1340.
2. HANG, L. M., S. IZU, and F. J. DIXON 1981. (NZW x BXSB)F1 hybrid, a model of acute lupus and coronary vascular disease with myocardial infarction. J. Exp. Med. 154: 216.
3. OYAIZU, N., R. YASUMIZU, M. MIYAMA-INABA, S., NOMURA, H. YOSHIDA, S. MIYAWAKI, Y. SHIBATA, S. MITSUOKA, K. YASUNAGA, S. MORII, R. A. GOOD, and S. IKEHARA. 1988. (NZW x BXSB)F1 mouse, a new animal model of idiopathic thrombocytopenic purpura. J. Exp. Med. 167: 2017.
4. YOSHIDA, H., H. FUJIWARA, T. FUJIWARA, S. IKEHARA, and Y. HAMASHIMA. 1987. Quantitative analysis of myocardial infarction in (NZW x BXSB)F1 hybrid mice with systemic lupus erythematosus and small coronary artery disease. Am. J. Pathol. 129: 477.
5. IKEHARA, S., R. A. GOOD, T. NAKAMURA, K. SEKITA, S. INOUE, OO. MANG, E. MUSO, K. ORAWA, and Y. HAMASHIMA. 1985. Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc. Natl. acad. Sci. USA 82: 2483.
6. IKEHARA, S., H. OHTSUKI, R. A. GOOD, H. ASAMOTO, T. NAKAMURA, K. SEKITA, E. MUSO, Y. TOCHINO, T. IDA, H. KUZUYA, H. IMURA, and Y. HAMASHIMA. 1985. Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation. Proc. Natl. Acad. Sci. USA 82: 7743.
7. YASUMIZU, R., K. SUGIURA, H. IWAI, M. INABA, S. MAKINO, T. IDA, H. IMURA, Y. HAMASHIMA, R. A. GOOD, and S. IKEHARA. 1985. Treatment of type 1 diabetes mellitus in nonobese diabetic mice by transplantation of allogenic bone marrow and pancreatic tissue. Proc. Natl. Acad. Sci. USA 84: 6555.
8. IKEHARA, S., M. INABA, S. ISHIDA, H. ISHIDA, H. HISHA, R. YASUMIZU, N. OYAIZU, K. SUGIURA, J. TOKI, F. TAKAO, THAN SOE, M. KAWAMURA, N. NISHIOKA, N. NARATA, and R. A. GOOD. 1991. Rationale for transplantation of both allogeneic bone marrow and stromal cells in the treatment of autoimmune diseases. New Strategies in Bone Marrow Transplantation. UCLA Symposia on Molecular and Cellular Biology, New Series. 137 p. 251. Wiley-Liss, New York.
9. IKEHARA, S., R. YASUMIZU, M. INABA, S. IZUI, K. HAYAKAWA, K. SEKITA, J. TOKI, K. SUGIURA, H. IWAI, T. NAKAMURA, E. MUSO, Y. HAMASHIMA, and R. A. GOOD. 1989. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogenic bone marrow transplantation. Proc. Natl. Acad. Sci. USA 86: 3305.
10. IKEHARA, S., M. KAWAMURA, F. TAKAO, M. INABA, R. YASUMIZU, THAN SOE, H. HISHA, K. SUGIURA, Y. KOIDE, T. O. YOSHIDA, T. IDA, H. IMURA, and R. A. GOOD. 1990. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 87: 8341.
11. KAWAMURA, M., H. HISHA, Y. LI, S. FUKUHARA, and S. IKEHARA. 1997. Distinct qualitative differences between normal and abnormal hemopoietic stem cells in vivo and in vitro. Stem. Cells 15: 56.
12. HANG, L. E., A. N. THEOFILOPOULOS, R. S. BALDERAS, S. J. FRANCIS, and F. J. DIXON. 1984. The effect of thymectomy on lupus-prone mice. J. Immuno. 132: 1809.
13. GERSHWIN, M. E., Y. OHSUGI, A. AHMED, J. J. CASTLES, R. SCIBIENSKI, and R. M. IKEDA. 1980. Studies of congenitally immunological mutant New Zealand mice. IV. Development of autoimmunity in congenitally athymic (nude) New Zealand Black x White F1 hybrid mice. J. Immunol. 125: 1189.
14. WOFSY, D., J. A. LEDBETTER, P. L. HENDLER, and W. E. SEAMAN. 1985. Treatment of murine lupus with monoclonal anti-T cell antibody. J. Immunol. 134: 852.
15. WOFSY, D., and W. E. SEAMAN. 1985. Successful treatment of autoimmunity in NZB/NZWF1 mice with monoclonal antibody to L3T4. J. Expl. Med. 161: 378.
16. SANTORO, T. J., J. P. PORTANOVA, and B. L. KOTZIN. 1988. The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice. J. Exp. Med. 167: 1713.
17. JABS, D. J., C. L. BUREK, HU QILE, R. C. KUPPERS, B. LEE, and R. A. PRENDERGAST. 1992. Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/Mp-lpr/lpr mice. Cell Immunol. 141: 496.
18. WOFSY, D. (1993). Treatment of murine lupus with anti-CD4 monoclonal antibodies. Immunology series 59: 221.
19. GIESE, T., and W. F. DAVIDSON. 1993. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production. J. Immunol. 152: 2000.
20. NAGATA, N., R. YASUMIZU, Y. ONISHI, T. NAKAGAWA, M. INABA, and S. IKEHARA. 1990. Auto-MHC class-II-reactive T cell line obtained from MRL/+ mice suffering from lpr-GVHD I. Characterization of surface phenotypes, specificities and functions in vitro. Immunobiol. 181: 367.
21. SOE THAN, H. ISHIDA, M. INABA, Y. FUKUBA, Y. SEINO, M. ADACHI, H. IMURA, and S. IKEHARA. 1992. Bone marrow transplantation as a strategy for treatment of non-insulin-dependent diabetes mellitus in KK-Ay mice. J. Exp. Med. 176: 1233.
22. ADACHI, Y., M. INABA, Y. AMOH, H. YOSHIFUSA, Y. NAKAMURA, H. SUZUKA, S. AKAMATSU, S. NAKAI, H. HARUNA, M. ADACHI, H. GENBA, and S. IKEHARA. 1995. Effect of bone marrow transplantation on anti-phospholipid antibody syndrome in murine lupus mice. Immunobiol. 192: 218.
23. ADACHI, Y., M. INABA, K. INABA, N. NAGATA, Y. KOBAYASHI, and S. IKEHARA. 1993. Functional analyses of B cells in (NZW x BXSB)F1 mice. Autoimmunity 15: 99.
24. ROMAGNANI, S. 1997. The Th1/Th2 paradigm. Immunol. Today 18: 263.
25. MONTOGOMERY, R. A., and M. J. DALLMAN. 1991. Analysis of cytokine gene expression during fetal thymic ontogeny using the polymerase chain reaction. J. Immunol. 147: 554.
26. ISHIDA, H., T. MUCHAMUEL, S. SAKAGUCHI, S. ANDRADE, S. MENON, and M. HOWARD. 1994. Continous administration of anti-interleukin 10 antibodies delays of onset of autoimmunity in NZB/W mice. J. Exp. Med. 179: 305.
27. JACOB, C. O., P. H. VAN DER MEIDE, and H. O. MCDEVITT. 1987. In vivo treatment of (NZB x NZW)F1 lupus-like nephritis with monoclonal antibody to γ interferon. J. Exp. Med. 166: 798.
28. + cell subsets and lymphokine production in BXSB mice. J. Immunol. 152: 4129.
29. FINCK, B. K., B. CHAN, and D. WOFSY. 1994. Interleukin 6 promotes murine lupus on NZB/NZW F1 mice. J. Clin. Invest. 94: 585.
30. TAKAHASHI, S., L. FODDATI, M. IWAMOTO, R. MERINO, R. MOTTA, T. KOBAYASHI, and S. IZUI. 1996. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J. Clin. Invest. 97: 1597.
31. GUTIERREZ-RAMOS, J. C., J. L. ANDREU, M. A. MARCOS, I. R. VEGAZO, and C. MARTINEZ. 1991. Treatment with IL-2/vaccinia recombinant virus leads to serologic, histologic and phenotypic normalization of autoimmune MRL/lpr-lpr mice. Autoimmunity 10: 15-25.